◆ TICKERBASEOpen interactive view →
◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

HomeAll stocksI › ISRG

Intuitive Surgical Inc (ISRG) Financial History

20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

HEALTHCARE · Health Care Equipment · DATA UPDATED 2026-08-16

Intuitive Surgical Inc (ISRG) operates in the Health Care Equipment industry and is headquartered in Sunnyvale, United States with about 17,021 employees. Its market capitalization is roughly $141 billion. In the fiscal year ended 2025-12-31, ISRG reported $10.1B in revenue and $2.9B in net income.

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally.

Interactive charts & full statements → Open the ISRG valuation workbench →

ISRG Revenue & Earnings History — Annual Income Statement

Income statementTTM → 2026-06-302025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-31
Total Revenue$11.0B$10.1B$8.4B$7.1B$6.2B$5.7B$4.4B$4.5B$3.7B$3.1B$2.7B$2.4B$2.1B$2.3B$2.2B$1.8B$1.4B$1.1B$875M$601M$373M
Gross Profit$7.4B$6.6B$5.6B$4.7B$4.2B$4.0B$2.9B$3.1B$2.6B$2.2B$1.9B$1.6B$1.4B$1.6B$1.6B$1.3B$1.0B$751M$621M$414M$248M
Gross Margin %66.7%66.0%67.5%66.4%67.4%69.3%65.6%69.5%69.9%70.1%69.9%66.2%66.3%70.4%72.1%72.5%72.9%71.4%71.0%69.0%66.5%
Operating Income (EBIT)$3.5B$2.9B$2.3B$1.8B$1.6B$1.8B$1.1B$1.4B$1.2B$1.1B$945M$740M$545M$852M$878M$695M$555M$377M$311M$207M$107M
Operating Margin %31.3%29.3%28.1%24.8%25.4%31.9%24.1%30.7%32.2%33.7%34.9%31.0%25.6%37.6%40.3%39.5%39.3%35.9%35.5%34.4%28.8%
Net Income$3.1B$2.9B$2.3B$1.8B$1.3B$1.7B$1.1B$1.4B$1.1B$660M$736M$589M$419M$671M$657M$495M$382M$233M$204M$145M$72M
Net Margin %28.4%28.4%27.8%25.2%21.2%29.8%24.3%30.8%30.3%21.1%27.2%24.7%19.7%29.6%30.1%28.2%27.0%22.1%23.4%24.1%19.3%
EBITDA$4.5B$4.0B$3.1B$2.4B$2.0B$2.1B$1.3B$1.6B$1.3B$1.2B$1.0B$830M$619M$920M$936M$741M$596M$412M$336M$220M$143M
Earnings Per Share (EPS)$8.72$7.87$6.42$5.03$3.65$4.66$2.94$3.85$3.16$1.89$2.08$1.73$1.23$1.86$1.78$1.37$1.05$0.66$0.57$0.41$0.21
Shares Outstanding (M)358M363M362M357M362M366M361M359M356M349M354M341M339M361M370M362M363M353M359M351M343M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

ISRG Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-30
Total Revenue$2.9B$2.8B$2.9B$2.5B$2.4B$2.3B$2.4B$2.0B
Gross Profit$2.0B$1.8B$1.9B$1.7B$1.6B$1.5B$1.6B$1.4B
Gross Margin %67.8%66.1%66.4%66.4%66.3%64.7%68.0%67.4%
Operating Income (EBIT)$972M$855M$864M$760M$743M$578M$735M$577M
Operating Margin %33.6%30.9%30.1%30.3%30.5%25.7%30.4%28.3%
Net Income$818M$822M$795M$704M$658M$698M$686M$565M
Net Margin %28.3%29.6%27.7%28.1%27.0%31.0%28.4%27.7%
EBITDA$1.2B$1.1B$1.2B$1.0B$987M$809M$934M$787M
Earnings Per Share (EPS)$2.28$2.28$2.21$1.95$1.81$1.92$1.88$1.56
Shares Outstanding (M)358M360M360M362M364M365M364M363M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

ISRG Free Cash Flow History

Cash flowTTM → 2026-06-302025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-31
Cash from Operations (CFO)$3.7B$3.0B$2.4B$1.8B$1.5B$2.1B$1.5B$1.6B$1.2B$1.1B$1.0B$772M$665M$880M$814M$678M$528M$385M$278M$206M$100M
Capital Expenditures (CapEx)$484M$540M$1.1B$1.1B$532M$354M$342M$426M$187M$191M$54M$81M$106M$105M$142M$83M$96M$53M$106M$24M$18M
Free Cash Flow (FCF)$3.2B$2.5B$1.3B$750M$958M$1.7B$1.1B$1.2B$982M$953M$989M$691M$560M$775M$672M$595M$432M$332M$172M$182M$82M
FCF Margin %29.2%24.8%15.6%10.5%15.4%30.4%26.2%26.2%26.4%30.5%36.6%29.0%26.2%34.2%30.9%33.8%30.6%31.5%19.7%30.2%21.9%
Dividends Paid$8M$0M$0M$0M$0M$0M$0M$0M$0M$0M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

ISRG Quarterly Free Cash Flow — Last 8 Quarters

Quarterly cash flow2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-30
Cash from Operations (CFO)$1.1B$912M$892M$841M$715M$582M$823M$706M
Capital Expenditures (CapEx)$113M$103M$162M$105M$155M$117M$312M$248M
Free Cash Flow (FCF)$948M$809M$730M$736M$560M$465M$511M$459M
FCF Margin %32.8%29.2%25.5%29.4%22.9%20.6%21.2%22.5%
Dividends Paid$8M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

ISRG Balance Sheet History

Balance sheet2026-06-302025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-31
Total Assets$20.9B$20.6B$18.8B$15.4B$13.0B$13.6B$11.2B$9.7B$7.8B$5.8B$6.5B$4.9B$4.0B$4.0B$4.1B$3.1B$2.4B$1.8B$1.5B$1.0B$672M
Cash & Cash Equivalents$2.8B$3.4B$2.0B$2.8B$1.6B$1.3B$1.6B$1.2B$858M$3.8B$4.8B$3.3B$2.5B$782M$554M$2.2B$1.6B$1.2B$195M$123M$34M
Total Liabilities$2.6B$2.7B$2.3B$2.0B$1.9B$1.6B$1.4B$1.4B$1.2B$1.0B$709M$588M$580M$449M$479M$418M$353M$272M$208M$151M$82M
Total Debt (Short + Long-Term)$0M$39M$34M$25M$24M$20M$22M$569M$39M$372M$144M$103M$81M$5M$83M$96M$78M$69M$0M$0M$0M
Total Shareholders' Equity$18.2B$17.8B$16.4B$13.3B$11.0B$12.0B$9.8B$8.3B$6.7B$4.7B$5.8B$4.3B$3.4B$3.5B$3.6B$2.6B$2.0B$1.5B$1.3B$889M$590M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive ISRG viewer.

ISRG Metric Deep Dives

Other Companies in Health Care Equipment

This page in other languages: עברית · Русский · Español · Português · 中文 · العربية · Français · Italiano · 日本語 · Deutsch · فارسی · हिन्दी

← ISRAAll “I” companiesISRL →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.